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THE ROLE OF MMP-2, 9, AND 13, IN THE REGULATION OF SKELETAL MUSCLE 
HYPERTROPHY FOLLOWING FUNCTIONAL OVERLOAD
Reilly E. Fitzpatrick1, Gary E. McCall, PhD1, Ryan S. Mehan, PhD1, J-P Hyatt, PhD2, Jung A. Kim, PhD1
1Department of Exercise Science, University of Puget Sound and 2Department of Human Science, Georgetown University
PURPOSE: Skeletal muscle is the most abundant tissue in vertebrates that functions primarily to
generate locomotion, and exhibits a high degree of structural and functional plasticity that is largely
dependent on the level of activity placed on it. Recent studies have shown that a family of enzymes
known as matrix metalloproteinases (MMPs) play an important role in regulating this plasticity.
Specifically, MMP-2 and MMP-9 degrade components of the extracellular matrix (ECM) surrounding
muscle fiber during periods of growth and repair. However, the mechanisms by which these MMPs
mediate this response and how each contributes to muscle repair and remodeling remains largely
unknown. The purpose of this study was to examine the relationship between MMP-2, -9, and -13 in
functionally overloaded (FO) mouse plantaris muscle, and determine what effect the absence of MMP-9
has on the expression of MMP-2 and MMP-13 in hypertrophying muscle. METHODS: FO of the
plantaris muscle was performed on 10 wild type (WT) and 10 MMP-9 knockout (KO) mice. The plantaris
muscle was then harvested at baseline (0-day) and 2- and 14-days after FO. RT-PCR experiments were
performed to determine the mRNA expression levels of MMP-2, -9, and -13. RESULTS: MMP-2 and
MMP-13 mRNA expression was significantly higher after 14-days FO compared to baseline (0-day) in
both the WT and KO mice. MMP-9 mRNA expression was down-regulated after 14-days FO.
CONCLUSIONS: MMP-2 and MMP-13 may play a more central role in hypertrophy than MMP-9.
Additionally, there was no early expression from MMP-2 or MMP-13 in the KO, suggesting another
molecular player is compensating for MMP-9 or that MMP-9 may not be essential in hypertrophy
following FO.
Abstract
Results
Materials & Methods
Materials & Methods
Step 1: isolation of RNA from plantaris muscle
Step 2: reverse transcription with oligo(dT)20
primers to generate cDNA
Step 3: PCR
Step 4: analysis of RT-PCR products on a 1% 
agarose gel
• All cells in multicellular organisms are surrounded by an extracellular
matrix (ECM). In skeletal muscle, the ability of the ECM to undergo
changes in response to increased or decreased activity is an important
component of its plastic nature.
• Matrix metalloproteinases (MMPs) are a group of enzymes that regulate
the maintenance of the ECM with MMP-2 and MMP-9 being most
prevalent in skeletal muscle (1,2).
• Recent studies have identified MMP-13 as another key enzyme required
for muscle remodeling via ECM regulation, and has been shown to be up-
regulated under atrophying and hypertrophying conditions (3,4).
• Functional overload (FO) is a model used to induce muscle hypertrophy
by surgical removal of the major synergists that perform similar
functions, i.e., ankle extension.
• Previous studies have shown that MMP-2 and MMP-9 expression occurs
in a time-dependent manner with MMP-9 expression up-regulated at 2
days after FO and MMP-2 expression up-regulated at 14 days after FO,
suggesting a unique function for each MMP (5).
• In this study MMP-9 knockout (KO) mice were used to further elucidate the
role of MMP-9 in regulating skeletal muscle plasticity, and to demonstrate
whether other MMPs have overlapping function with MMP-9 after FO.
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• MMP-2 and MMP-13 mRNA expression was significantly higher after 14-
days FO in both the WT and MMP-9 KO mice compared to baseline (0-
day).
• MMP-2 mRNA expression was higher after 2-days FO in WT, but not in
the KO mice, though this difference was not statistically significant. The
increased expression of MMP-2 could be attributed to the increased
relative muscle weight of the plantaris muscle observed in the WT mice
after 2-days FO that was not observed in the KO mice at the same time
point (data not shown). Our findings are in contrast to what has been
observed previously by Calve et al. (6) who showed that MMPs are
differentially expressed with MMP-9, not MMP-2, mRNA expression up-
regulated at 2-days FO. In fact, no changes in MMP-9 mRNA expression
was observed after 2-days FO compared to baseline (0-day).
• MMP-9 mRNA expression was down-regulated after 14-days FO,
consistent with previous findings (6).
• MMP-13 mRNA expression was up-regulated after 2- and 14-days FO in
both the WT and KO mice, suggesting its importance in skeletal muscle
hypertrophy.
• There appeared to be no redundant function of MMP-2 or MMP-13 with
MMP-9 in the KO group, suggesting that other factors may be
compensating for MMP-9, or that MMP-9 may not be essential under
hypertrophying conditions induced by FO.
• Increasing the sample size from all groups at all time points with
additional experiments will provide better resolution of the mRNA
expression patterns for all MMPs.
• As MMPs are subject to post-translational regulation, determining the
active form of these enzymes is essential and should provide a clearer
picture of the potential function of each MMP in these studies. Gel
zymography will be performed to assess MMP-2 and MMP-9 activity,
and Western blot analyses will be performed to assess MMP-13
expression.
• Further elucidation of the relationship between individual MMPs and the
mechanisms by which they regulate muscle regeneration, growth, and
repair will increase our current understanding of MMP interactions in
skeletal muscle and their potential function during muscle adaptation.
Future Directions
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Agarose gels showing the expression of MMP-2, MMP-9, and MMP-13 in the plantaris muscle in
wild type (WT) and MMP-9 knockout (KO) mice at 0-d (baseline), and 2- and 14-d after FO. A
264-bp partial cDNA fragment of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as a loading control for each transcript. Lanes M represent the 100 bp DNA ladder. d; day
mRNA expression levels of MMP-2, MMP-9, and
MMP-13 in plantaris based on RT-PCR analyses
from WT (white bars) and KO (black bars) mice.
Data is presented as arbitrary units (AU) relative to
GAPDH expression. Values are presented as
mean ± SEM. *significantly different from 0-d at
p≤0.05. d; day
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A sample size of 5 mice were used for both the wild type
(WT) and MMP-9 knockout (KO) groups for each time point:
0-day (baseline), and 2- and 14-days after FO.
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